After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The company's hepatitis C drug division is expected to see losses in the second half of the year.
These 10 dividend aristocrat stocks offer an average high yield of 3% and have increased dividends for 46 consecutive years on average.
Time to lock in gains in JNJ.
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.